Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 214 523 | déclaré | 31 déc. 2025 | tx 345+9 024 583−8 915 550 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 31 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 28 570 | 772.09 USD | |
| 31 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28 570 | 0.00 USD | |
| 31 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28 570 | 0.00 USD | deriv |
| 09 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 172 723 | 555.67 USD | |
| 09 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 155 145 | 701.51 USD | |
| 09 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 172 723 | 0.00 USD | deriv |
| 11 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 7 321 | 1015.28 USD | |
| 12 juin 2024 | CONVERSION | REGENERON PHARMACEUTICALS, INC. | 1 000 | 0.00 USD | |
| 12 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 270 | 1016.62 USD | |
| 12 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 14 879 | 1015.30 USD | |
| 11 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 743 | 1016.04 USD | |
| 12 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 1025.27 USD | |
| 12 juin 2024 | CONVERSION | REGENERON PHARMACEUTICALS, INC. | 1 000 | 0.00 USD | deriv |
| 06 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 787 | 1015.02 USD | |
| 17 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 22 687 | 979.22 USD | |
| 17 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 143 | 980.07 USD | |
| 13 mai 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 203 204 | 399.66 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 299 | 988.76 USD | |
| 13 mai 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 144 433 | 976.79 USD | |
| 14 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 22 698 | 979.16 USD | |
| 14 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2 302 | 980.10 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 7 864 | 979.05 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 295 | 980.64 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 081 | 981.50 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 235 | 982.66 USD |